Kenvue rises after quarterly results beat

Shares of Tylenol maker Kenvue KVUE.N rise as much as 8.9% to a near two-year high of $25.17

Stock set for best day in almost a year, if gains hold

KVUE says it earned a profit of 24 cents per share vs analysts' estimates of 23 cents per share - data compiled by LSEG

Reports Q1 revenue of $3.74 billion vs estimates of $3.67 billion

KVUE expects 2025 profit to remain flat year-over-year, anticipating higher costs

*Company says it anticipates a $150 million impact from President Donald Trump's trade tariffs on U.S. imports thus far

Co had previously forecast 2025 profit to be flat to 2% growth

Separately, company appoints Amit Banati as chief financial officer, effective May 12

Including session's moves, stock has risen ~15% YTD